The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2023 Jun 5

PMID 37275941

Authors

Huiling Chen

Xiaojing Huang

Meiyuan Dong

Song Wen

Ligang Zhou

Xinlu Yuan

Affiliations

Soon will be listed here.

Abstract

Diabetes and sarcopenia are emerging as serious public health issues. Sarcopenia, an age-related disorder characterized by loss of skeletal muscle mass and function, is recognized as a new complication in elderly patients with type 2 diabetes mellitus (T2DM). Type 2 diabetes is characterized by insulin resistance, chronic inflammation, accumulation of advanced glycation products and increased oxidative stress, which can negatively affect skeletal muscle mass, strength and function leading to sarcopenia. There is a mutual interrelationship between T2DM and sarcopenia in light of pathophysiology mechanism and long-term outcome. T2DM will accelerate the decline of muscle mass and function, which will in turn lead to glucose metabolism disorders, reduced physical activity and the risk of diabetes. However, the specific mechanism involved has not been thoroughly studied. Therefore, this review aims to explore the pathophysiology and therapeutic strategy related to sarcopenia and diabetes and provide insight for future investigations, which is of great significance for improving the quality of life in the elderly with diabetes and concurrently reducing the incidence of related complications.

Citing Articles

The efficacy of Sarcomeal® oral supplementation plus vitamin D3 on muscle parameters, metabolic factors, and quality of life in diabetic sarcopenia: a randomized controlled clinical trial.

Abdi Dezfouli R, Zargar Balajam N, Heshmat R, Shafiee G Aging Clin Exp Res. 2025; 37(1):81.

PMID: 40075050 PMC: 11903600. DOI: 10.1007/s40520-025-02969-x.

Are strategies to increase muscle mass and strength as effective in people with type 2 diabetes?.

Al-Awadi A, Gray S, Al-Ozairi E Rev Endocr Metab Disord. 2025; .

PMID: 39998784 DOI: 10.1007/s11154-025-09947-8.

Increased ectodysplasin-A2-receptor EDA2R is a ubiquitous hallmark of aging and mediates parainflammatory responses.

Barbera M, Guarrera L, Re Cecconi A, Cassanmagnago G, Vallerga A, Lunardi M Nat Commun. 2025; 16(1):1898.

PMID: 39988718 PMC: 11847917. DOI: 10.1038/s41467-025-56918-3.

Personalised screening tool for early detection of sarcopenia in stroke patients: a machine learning-based comparative study.

Yan H, Li J, Li Y, Xian L, Tang H, Zhao X Aging Clin Exp Res. 2025; 37(1):40.

PMID: 39979762 PMC: 11842499. DOI: 10.1007/s40520-025-02945-5.

Medical Nutrition Therapy and Physical Exercise for Acute and Chronic Hyperglycemic Patients with Sarcopenia.

Abad-Gonzalez A, Veses S, Argente Pla M, Civera M, Garcia-Malpartida K, Sanchez C Nutrients. 2025; 17(3).

PMID: 39940355 PMC: 11820730. DOI: 10.3390/nu17030499.

References

Ganapathy A, Nieves J . Nutrition and Sarcopenia-What Do We Know?. Nutrients. 2020; 12(6). PMC: 7353446. DOI: 10.3390/nu12061755. View

Dent E, Morley J, Cruz-Jentoft A, Arai H, Kritchevsky S, Guralnik J . International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging. 2018; 22(10):1148-1161. DOI: 10.1007/s12603-018-1139-9. View

Rong Y, Bian A, Hu H, Ma Y, Zhou X . Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10. BMC Geriatr. 2018; 18(1):308. PMC: 6292155. DOI: 10.1186/s12877-018-1007-9. View

Yokota T, Kinugawa S, Hirabayashi K, Suga T, Takada S, Omokawa M . Pioglitazone improves whole-body aerobic capacity and skeletal muscle energy metabolism in patients with metabolic syndrome. J Diabetes Investig. 2016; 8(4):535-541. PMC: 5497029. DOI: 10.1111/jdi.12606. View

Argyropoulou D, Geladas N, Nomikos T, Paschalis V . Exercise and Nutrition Strategies for Combating Sarcopenia and Type 2 Diabetes Mellitus in Older Adults. J Funct Morphol Kinesiol. 2022; 7(2). PMC: 9225431. DOI: 10.3390/jfmk7020048. View

Massimino E, Izzo A, Riccardi G, Della Pepa G . The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms. Cells. 2021; 10(8). PMC: 8393336. DOI: 10.3390/cells10081958. View

Low S, Wang J, Moh A, Ang S, Ang K, Shao Y . Amino acid profile of skeletal muscle loss in type 2 diabetes: Results from a 7-year longitudinal study in asians. Diabetes Res Clin Pract. 2022; 186:109803. DOI: 10.1016/j.diabres.2022.109803. View

Xu J, Wan C, Ktoris K, Reijnierse E, Maier A . Sarcopenia Is Associated with Mortality in Adults: A Systematic Review and Meta-Analysis. Gerontology. 2021; 68(4):361-376. DOI: 10.1159/000517099. View

Volpi E, Nazemi R, Fujita S . Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care. 2004; 7(4):405-10. PMC: 2804956. DOI: 10.1097/01.mco.0000134362.76653.b2. View

10.

Bouter K, van Raalte D, Groen A, Nieuwdorp M . Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction. Gastroenterology. 2017; 152(7):1671-1678. DOI: 10.1053/j.gastro.2016.12.048. View

11.

Yaribeygi H, Farrokhi F, Butler A, Sahebkar A . Insulin resistance: Review of the underlying molecular mechanisms. J Cell Physiol. 2018; 234(6):8152-8161. DOI: 10.1002/jcp.27603. View

12.

Doucet J, Chacra A, Maheux P, Lu J, Harris S, Rosenstock J . Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus. Curr Med Res Opin. 2011; 27(4):863-9. DOI: 10.1185/03007995.2011.554532. View

13.

Meier N, Lee D . Physical activity and sarcopenia in older adults. Aging Clin Exp Res. 2019; 32(9):1675-1687. DOI: 10.1007/s40520-019-01371-8. View

14.

Aragno M, Mastrocola R, Catalano M, Brignardello E, Danni O, Boccuzzi G . Oxidative stress impairs skeletal muscle repair in diabetic rats. Diabetes. 2004; 53(4):1082-8. DOI: 10.2337/diabetes.53.4.1082. View

15.

Degens H, Veerkamp J . Changes in oxidative capacity and fatigue resistance in skeletal muscle. Int J Biochem. 1994; 26(7):871-8. DOI: 10.1016/0020-711x(94)90079-5. View

16.

Jimenez-Gutierrez G, Martinez-Gomez L, Martinez-Armenta C, Pineda C, Martinez-Nava G, Lopez-Reyes A . Molecular Mechanisms of Inflammation in Sarcopenia: Diagnosis and Therapeutic Update. Cells. 2022; 11(15). PMC: 9367570. DOI: 10.3390/cells11152359. View

17.

Goyal R, Faizy A, Siddiqui S, Singhai M . Evaluation of TNF-α and IL-6 Levels in Obese and Non-obese Diabetics: Pre- and Postinsulin Effects. N Am J Med Sci. 2012; 4(4):180-4. PMC: 3334258. DOI: 10.4103/1947-2714.94944. View

18.

Hirata Y, Nomura K, Senga Y, Okada Y, Kobayashi K, Okamoto S . Hyperglycemia induces skeletal muscle atrophy via a WWP1/KLF15 axis. JCI Insight. 2019; 4(4). PMC: 6478420. DOI: 10.1172/jci.insight.124952. View

19.

Wust R, Morse C, de Haan A, Rittweger J, Jones D, Degens H . Skeletal muscle properties and fatigue resistance in relation to smoking history. Eur J Appl Physiol. 2008; 104(1):103-10. PMC: 2480601. DOI: 10.1007/s00421-008-0792-9. View

20.

Goodpaster B, Park S, Harris T, Kritchevsky S, Nevitt M, Schwartz A . The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006; 61(10):1059-64. DOI: 10.1093/gerona/61.10.1059. View